Review of McDonald criteria (ORP-20)
Diagnostic criteria in MS facilitate a rapid diagnosis of CIS or relapsing-remitting MS (RRMS) in patients who present with typical demyelinating syndromes. Previous criteria, including the Poser criteria, focused exclusively on clinical symptoms and signs. The emergence of the McDonald criteria in...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Iran University of Medical Sciences
2023-01-01
|
| Series: | Neurology Letters |
| Subjects: | |
| Online Access: | https://www.neurologyletters.com/article_184170_d41d8cd98f00b204e9800998ecf8427e.pdf |
| _version_ | 1797364119968415744 |
|---|---|
| author | Atefeh Eidi |
| author_facet | Atefeh Eidi |
| author_sort | Atefeh Eidi |
| collection | DOAJ |
| description | Diagnostic criteria in MS facilitate a rapid diagnosis of CIS or relapsing-remitting MS (RRMS) in patients who present with typical demyelinating syndromes.
Previous criteria, including the Poser criteria, focused exclusively on clinical symptoms and signs. The emergence of the McDonald criteria in 2001 marked a new era in the diagnosis of MS where paraclinical criteria were incorporated so that the hallmark features of dissemination in space and dissemination in time could be met using a combination of clinical and MRI features
The McDonald criteria have since undergone numerous revisions (2005, 2010, and most recently 2017). The latest revisions of the McDonald criteria have the benefit of higher sensitivity but also have a slight decrease in specificity compared with previous iterations
Current MS diagnostic criteria facilitate the early diagnosis of MS in people presenting with typical clinical syndromes, allowing for the initiation of DMT in appropriate patients. However, the diagnosis can be challenging for several reasons, and diagnostic criteria should be used cautiously in patients presenting with atypical syndromes and those in special populations in whom the criteria have not yet been adequately validated. Clinical judgment and existing paraclinical tools are useful in minimizing misdiagnosis and facilitating an accurate diagnosis of MS. |
| first_indexed | 2024-03-08T16:30:42Z |
| format | Article |
| id | doaj.art-dfc36bc926804c97a67215773ca543a1 |
| institution | Directory Open Access Journal |
| issn | 2821-1723 |
| language | English |
| last_indexed | 2024-03-08T16:30:42Z |
| publishDate | 2023-01-01 |
| publisher | Iran University of Medical Sciences |
| record_format | Article |
| series | Neurology Letters |
| spelling | doaj.art-dfc36bc926804c97a67215773ca543a12024-01-06T08:20:06ZengIran University of Medical SciencesNeurology Letters2821-17232023-01-012Supplementary 1 (20th Iranian Multiple Sclerosis Congress)184170Review of McDonald criteria (ORP-20)Atefeh Eidi0Multiple sclerosis research center, Neuroscience institute, Tehran University of medical sciences, Tehran, IranDiagnostic criteria in MS facilitate a rapid diagnosis of CIS or relapsing-remitting MS (RRMS) in patients who present with typical demyelinating syndromes. Previous criteria, including the Poser criteria, focused exclusively on clinical symptoms and signs. The emergence of the McDonald criteria in 2001 marked a new era in the diagnosis of MS where paraclinical criteria were incorporated so that the hallmark features of dissemination in space and dissemination in time could be met using a combination of clinical and MRI features The McDonald criteria have since undergone numerous revisions (2005, 2010, and most recently 2017). The latest revisions of the McDonald criteria have the benefit of higher sensitivity but also have a slight decrease in specificity compared with previous iterations Current MS diagnostic criteria facilitate the early diagnosis of MS in people presenting with typical clinical syndromes, allowing for the initiation of DMT in appropriate patients. However, the diagnosis can be challenging for several reasons, and diagnostic criteria should be used cautiously in patients presenting with atypical syndromes and those in special populations in whom the criteria have not yet been adequately validated. Clinical judgment and existing paraclinical tools are useful in minimizing misdiagnosis and facilitating an accurate diagnosis of MS.https://www.neurologyletters.com/article_184170_d41d8cd98f00b204e9800998ecf8427e.pdfmultiple sclerosisdiagnosis |
| spellingShingle | Atefeh Eidi Review of McDonald criteria (ORP-20) Neurology Letters multiple sclerosis diagnosis |
| title | Review of McDonald criteria (ORP-20) |
| title_full | Review of McDonald criteria (ORP-20) |
| title_fullStr | Review of McDonald criteria (ORP-20) |
| title_full_unstemmed | Review of McDonald criteria (ORP-20) |
| title_short | Review of McDonald criteria (ORP-20) |
| title_sort | review of mcdonald criteria orp 20 |
| topic | multiple sclerosis diagnosis |
| url | https://www.neurologyletters.com/article_184170_d41d8cd98f00b204e9800998ecf8427e.pdf |
| work_keys_str_mv | AT atefeheidi reviewofmcdonaldcriteriaorp20 |